Novocure Enrolls First Patient in KEYNOTE-B36, a Pilot Study of Tumor Treating Fields Together with KEYTRUDA® for Patients with First-Line Stage III Non-Small Cell Lung Cancer – Business Wire

ST. HELIER, Jersey–(Enterprise WIRE)–Novocure (NASDAQ: NVCR) right now introduced The primary affected person has been enrolled in its half 2 pilot KEYNOTE-B36 research, carried out in collaboration with MSD, a tradeidentify of Merck & Co., Inc., Rahway, NJ, USA. KEYNOTE-B36 is designed To guage The safety and influenceiveness of Tumor Treating Fields (TTFields) Collectively with KEYTRUDA® (pembrolizumab), MSD’s anti-PD-1 remedy, for The primary-line remedy of regionally superior or metastatic intrathoracic non-small cell lung most cancers (NSCLC) that expresses PD-L1.

“That is An important subsequent step for our thoracic program,” said William Doyle, Novocure’s Authorities Chairman. “KEYNOTE-B36 recurrents Definitely one of Novocure’s 5 ongoing medical trials exploring the potential of Tumor Treating Fields To enrich immuncompletely differentapy brokers. We look forward to persevering with our research in halfnership with Merck in hopes of deal withing many extra affected individuals in want.”

KEYNOTE-B36 is a single arm, open-label half 2 pilot research anticipated to enroll 66 affected individuals. The first endpoint of the research is objective response price. Secondary endfactors embrace general survival, development free survival (PFS), PFS at six months, one-yr survival price, interval of response, illness administration price and frequency and severity of antagonistic events.

About Non-small Cell Lung Cancer

Lung most cancers Might be the Commonest Rationalization for most cancers-associated demise worldwide, …….

Source: https://www.businesswire.com/news/home/20220621005374/en/Novocure-Enrolls-First-Patient-in-KEYNOTE-B36-a-Pilot-Study-of-Tumor-Treating-Fields-Together-with-KEYTRUDA%C2%AE-for-Patients-with-First-Line-Stage-III-Non-Small-Cell-Lung-Cancer

Related Posts

npressfetimg-29461.png

New ‘digital masks’ touted as means of protecting patient privacy – Healthcare Finance News

Photo: Al David Sacks/Getty Images

Technologists writing in the journal Nature have created a digital “mask,” dubbed the DM, which they say offers a pragmatic approach to safeguarding patient privacy in electronic health records and during virtual healthcare visits.

There appear to be clinical benefits to the DM as well.

The technology is based on real-time 3D reconstructio…….

npressfetimg-28933.png

State Rules Stymie Patient Access to Care at Opioid Treatment Centers – PatientEngagementHIT.com

Checking if the site connection is secure

Enable JavaScript and cookies to continue

…….

npressfetimg-28758.png

Top Ranked for Quality & Patient Safety – NYU Langone Health

NYU Langone Health has the highest quality of care and patient safety rankings of any healthcare organization in the country. Each day, we ensure that we are delivering the best in all aspects of care across our hospitals and health system. Our exceptional quality and safety standards have made us the top-rated healthcare system in the New York City area and placed us among the top-ranked …….

npressfetimg-28699.png

COVID-19 rehabilitation patient leaflet hugely popular – World Health Organization

Recognizing early that rehabilitation would be essential for many in their recovery from COVID-19 infection, WHO/Europe quickly convened experts and people recovering from COVID-19 to produce the patient leaflet ‘Support for rehabilitation: self-management after COVID-19-related illness’. 

The resource provides evidence-based support and advice for adults who are recovering from COVI…….

npressfetimg-27757.png

Uninsured, Publicly Insured Patients Face Implicit Bias in Health – PatientEngagementHIT.com

Checking if the site connection is secure

Enable JavaScript and cookies to continue

…….

npressfetimg-27698.png

AI Brings New Opportunities for Patient Financial Navigation – Managed Healthcare Executive

The confusing, data-intensive world of getting help with medical bills has become a fertile territory for software developers.

When patients need help paying for high-cost medical treatment, they face a good news/bad news scenario.

The good news is that drugmakers, private foundations, government agencies and others have myriad programs that can help many if not all. The bad: Actual…….

Leave a Reply

Your email address will not be published. Required fields are marked *